# Efficacy of Lactobacillus Paracasei LC19 on Type 2 Diabetes

> **NCT06639425** · NA · RECRUITING · sponsor: **Beijing Chao Yang Hospital** · enrollment: 60 (estimated)

## Conditions studied

- Type 2 Diabetes

## Interventions

- **DIETARY_SUPPLEMENT:** Lactobacillus paracasei LC19 supplementation
- **DIETARY_SUPPLEMENT:** Placebo probiotic milk powder

## Key facts

- **NCT ID:** NCT06639425
- **Lead sponsor:** Beijing Chao Yang Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-10-12
- **Primary completion:** 2026-10-14
- **Final completion:** 2026-12-31
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2025-02-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06639425

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06639425, "Efficacy of Lactobacillus Paracasei LC19 on Type 2 Diabetes". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06639425. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*